An outbreak of multiple serotypes of salmonella in New Zealand linked to consumption of contaminated tahini imported from Turkey.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25393669)

Published in Foodborne Pathog Dis on November 01, 2014

Authors

Shevaun Paine1, Craig Thornley, Maurice Wilson, Muriel Dufour, Kerry Sexton, Jim Miller, Grant King, Stephen Bell, Don Bandaranayake, Graham Mackereth

Author Affiliations

1: 1 Institute of Environmental Science and Research Ltd. , Wellington, New Zealand .

Articles by these authors

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis (2012) 8.02

Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One (2010) 2.04

Parallel independent evolution of pathogenicity within the genus Yersinia. Proc Natl Acad Sci U S A (2014) 1.83

How low can it go? Projecting ischaemic heart disease mortality in New Zealand to 2015. N Z Med J (2006) 1.74

Migrants and tuberculosis: analysing epidemiological data with ethnography. Aust N Z J Public Health (2008) 1.46

Safety and efficacy of epicardial cryoablation in a canine model. Heart Rhythm (2005) 1.45

The relationship between surface temperature, tissue temperature, microbubble formation, and steam pops. Pacing Clin Electrophysiol (2009) 1.39

Post-marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004-2006. Hum Vaccin (2007) 1.29

Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways. J Immunol (2004) 1.24

Finding a lost needle in laparoscopic surgery. Surg Laparosc Endosc Percutan Tech (2011) 1.18

Pre-hospital antibiotics for meningococcal disease remains low. N Z Med J (2011) 1.06

Pandemic (H1N1) 2009 and seasonal influenza A (H1N1) co-infection, New Zealand, 2009. Emerg Infect Dis (2010) 1.05

LFA-1-mediated T cell costimulation through increased localization of TCR/class II complexes to the central supramolecular activation cluster and exclusion of CD45 from the immunological synapse. J Immunol (2007) 1.03

A community and workplace outbreak of tuberculosis in Hawke's Bay in 2002. N Z Med J (2004) 1.00

TCR-dependent translational control of GATA-3 enhances Th2 differentiation. J Immunol (2010) 0.99

Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy. Oncogene (2003) 0.97

Engagement of CD28 outside of the immunological synapse results in up-regulation of IL-2 mRNA stability but not IL-2 transcription. J Immunol (2006) 0.96

Sexual function, incontinence, and wellbeing in women after rectal cancer--a review of the evidence. J Sex Med (2012) 0.95

Feasibility of submandibular gland preservation in neck dissection: A prospective anatomic-pathologic study. Head Neck (2010) 0.94

Signals and sequences that control CD28 localization to the central region of the immunological synapse. J Immunol (2008) 0.94

Alternative approaches to control--quo vadit? Vet Parasitol (2006) 0.94

Development of a rapid quantitative PCR assay for direct detection and quantification of culturable and non-culturable Escherichia coli from agriculture watersheds. J Microbiol Methods (2007) 0.93

The streptococcolytic enzyme zoocin A is a penicillin-binding protein. FEMS Microbiol Lett (2004) 0.88

A methods comparison for the isolation and detection of thermophilic Campylobacter in agricultural watersheds. J Microbiol Methods (2009) 0.86

Seroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore. Emerg Infect Dis (2013) 0.85

Vector competence of New Zealand mosquitoes for selected arboviruses. Am J Trop Med Hyg (2011) 0.85

Design and synthesis of cell potent BACE-1 inhibitors: structure-activity relationship of P1' substituents. Bioorg Med Chem Lett (2009) 0.85

Metabolic engineering of higher plants and algae for isoprenoid production. Adv Biochem Eng Biotechnol (2015) 0.84

Complete Pathological Response After Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer and Its Relationship to the Degree of T3 Mesorectal Invasion. Dis Colon Rectum (2016) 0.83

Novel integrating adenoviral/retroviral hybrid vector for gene therapy. Hum Gene Ther (2002) 0.83

Laboratory-confirmed transmission of vaccinia virus infection through sexual contact with a military vaccinee. J Clin Microbiol (2004) 0.82

Stable expression recognition abnormalities in unipolar depression. Psychiatry Res (2010) 0.82

Acute gastrointestinal illness in New Zealand: information from a survey of community and hospital laboratories. N Z Med J (2009) 0.82

Piroplasms of New Zealand seabirds. Parasitol Res (2014) 0.81

Cutting edge: A role for inside-out signaling in TCR regulation of CD28 ligand binding. J Immunol (2011) 0.81

Rickettsia felis infections, New Zealand. Emerg Infect Dis (2012) 0.80

A prospective case-control and molecular epidemiological study of human cases of Shiga toxin-producing Escherichia coli in New Zealand. BMC Infect Dis (2013) 0.80

Targeting of streptococci by zoocin A. FEMS Microbiol Lett (2007) 0.79

A Legionnaires' disease outbreak: a water blaster and roof-collected rainwater systems. Water Res (2007) 0.79

Spatial and temporal drivers of zoonotic pathogen contamination of an agricultural watershed. J Environ Qual (2012) 0.79

LFA-1 co-stimulation inhibits T(h)2 differentiation by down-modulating IL-4 responsiveness. Int Immunol (2005) 0.78

The Initial Health Assessment: an intervention to identify the supportive care needs of cancer patients. Support Care Cancer (2003) 0.78

The chondroitin sulfate form of invariant chain trimerizes with conventional invariant chain and these complexes are rapidly transported from the trans-Golgi network to the cell surface. Biochem J (2007) 0.78

Endoplasmic reticulum-associated degradation-induced dissociation of class II invariant chain complexes containing a glycosylation-deficient form of p41. J Immunol (2004) 0.77

Surveillance of vaccine breakthrough cases following MeNZB vaccination. N Z Med J (2008) 0.76

PFGE for Shiga toxin-producing Escherichia coli O157:H7 (STEC O157) and non-O157 STEC. Methods Mol Biol (2015) 0.76

Two New Zealand outbreaks of norovirus gastroenteritis linked to commercially farmed oysters. N Z Med J (2011) 0.76

Self-diagnosis of influenza during a pandemic: a cross-sectional survey. BMJ Open (2011) 0.76

An outbreak of Salmonella Typhimurium phage type 42 associated with the consumption of raw flour. Foodborne Pathog Dis (2013) 0.76

Variable titin-based stiffness adjustment in heart disease. Circulation (2003) 0.75

Electronic Sentinel Surveillance of Influenza-like Illness. Experience from a pilot study in New Zealand. Appl Clin Inform (2017) 0.75

Rescue of chimeric adenoviral vectors to expand the serotype repertoire. J Virol Methods (2007) 0.75

Adrenal Hodgkin lymphoma. Br J Haematol (2009) 0.75

Unanswered questions, the epidemiology of a community outbreak: meningococcal C disease in Northland, New Zealand, 2011. N Z Med J (2013) 0.75

A design fault in New Zealand's health research funding system exposed by pandemic influenza. N Z Med J (2009) 0.75

Cognitive stimulation by caregivers for people with dementia. Geriatr Nurs (2013) 0.75

Phytophotodermatitis in grounds operatives. Occup Med (Lond) (2005) 0.75

Conjugate addition of organocopper reagents to gamma-alkoxybutenolides and application to the synthesis of non-racemic alkyl cyclopentenones. Org Biomol Chem (2004) 0.75

Debunking the 'only 50%' myth: prevalence of established risk factors in New Zealanders with self-reported ischaemic heart disease. Aust N Z J Public Health (2005) 0.75

Paediatric tuberculosis in a Pacific Islands community in New Zealand. J Paediatr Child Health (2006) 0.75